Shanxi Zhendong Pharmaceutical Co.,Ltd (SHE:300158)

China · Delayed Price · Currency is CNY

5.21

+0.07 (1.36%)

Sep 30, 2026, 3:04 PM CST

Market Cap	5.17B -20.7%
Revenue (ttm)	2.42B -17.1%
Net Income	-401.72M
EPS	-0.41
Shares Out	992.30M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,051,044
Open	5.32
Previous Close	5.14
Day's Range	5.11 - 5.32
52-Week Range	4.47 - 7.81
Beta	0.19
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 27, 2026

About SHE:300158

Shanxi Zhendong Pharmaceutical Co.,Ltd, together with its subsidiaries, researches, develops, produces, and sells pharmaceutical drugs in China. The company offers drugs for oncology, dermatology, digestive, urological, and cardiovascular diseases, as well as seeds. It is also involved in the integrating seeds, seedling cultivation, planting, processing, storage; and provision of Chinese medicinal materials and processed medicinal slices. In addition, the company engages in the production of anti-tumor raw materials, small-volume injections, ly... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1995

Employees 3,695

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300158

Full Company Profile

Financial Performance

In 2025, SHE:300158's revenue was 2.78 billion, a decrease of -6.33% compared to the previous year's 2.97 billion. Losses were -301.06 million, -77.34% less than in 2024.

Financial Statements